Zentalis Pharmaceuticals, Inc.: common-stock repurchase payments

What this measure means

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Exact concept: us-gaap:PaymentsForRepurchaseOfCommonStock. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2023-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Zentalis Pharmaceuticals, Inc.: total assets
• Zentalis Pharmaceuticals, Inc.: total liabilities
• Zentalis Pharmaceuticals, Inc.: stockholders equity
• Zentalis Pharmaceuticals, Inc.: cash and cash equivalents
• Zentalis Pharmaceuticals, Inc.: net income or loss
• Zentalis Pharmaceuticals, Inc.: operating cash flow
• Zentalis Pharmaceuticals, Inc.: capital expenditure payments
• Zentalis Pharmaceuticals, Inc.: contract revenue excluding tax
• Zentalis Pharmaceuticals, Inc.: financing cash flow
• Zentalis Pharmaceuticals, Inc.: investing cash flow
• Zentalis Pharmaceuticals, Inc.: retained earnings or deficit
• Zentalis Pharmaceuticals, Inc.: basic weighted-average shares
• Zentalis Pharmaceuticals, Inc.: diluted weighted-average shares
• Zentalis Pharmaceuticals, Inc.: basic earnings per share
• Zentalis Pharmaceuticals, Inc.: diluted earnings per share
• Zentalis Pharmaceuticals, Inc.: income tax expense or benefit
• Zentalis Pharmaceuticals, Inc.: net property, plant and equipment
• Zentalis Pharmaceuticals, Inc.: share-based compensation expense
• Zentalis Pharmaceuticals, Inc.: operating income or loss
• Zentalis Pharmaceuticals, Inc.: current assets
• Zentalis Pharmaceuticals, Inc.: current liabilities
• Zentalis Pharmaceuticals, Inc.: current accounts payable
• Zentalis Pharmaceuticals, Inc.: goodwill carrying amount
• Zentalis Pharmaceuticals, Inc.: net current accounts receivable
• Zentalis Pharmaceuticals, Inc.: operating expenses
• Zentalis Pharmaceuticals, Inc.: research and development expense

Inspect the source

Entity

Zentalis Pharmaceuticals, Inc. / CIK 0001725160

Captured

2026-09-21T17:25:13.615Z

SEC response SHA-256

54c6d1c54d3a4543b4fc4822693bfe782e6a69677007cf585f2b53a46df2979d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001725160.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))